Filters
Other countries
Results: 1 to 20 of 20
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
DHH - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Disorders of Sex Development Panel Invitae United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
DHH-related Differences of Sex Development via the DHH Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Custom XomeDx Slice – Differences of Sex Development (Proband Only) GeneDx United States | 21 | 112 |
|
46,XY sex reversal: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 11 | 10 |
|
Fulgent Genetics United States | 16 | 9 |
|
Fulgent Genetics United States | 92 | 56 |
|
Fulgent Genetics United States | 76 | 41 |
|
Gonadal Dysgenesis/ Agenesis , Panel Massive Sequencing (NGS) SRY, NR5A1, DHH, AK2 Reference Laboratory Genetics Spain | 7 | 4 |
|
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Panel Genetic Services Laboratory University of Chicago United States | 27 | 33 |
|
46,XY complete gonadal dysgenesis Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
46XY partial gonadal dysgenesis, with minifascicular neuropathy MedGene Slovakia | 1 | 1 |
|
46XY partial gonadal dysgenesis, with minifascicular neuropathy Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.